Skip to main content

Venous Disease

0
Pipeline Programs
2
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Innovation Pharmaceuticals
4 programs
InsolesN/A1 trial
InsolesN/A1 trial
InsolesN/A1 trial
InsolesN/A1 trial
Active Trials
NCT06395025Completed110Est. Feb 2024
NCT06153680Completed52Est. Jun 2023
NCT07234240Completed54Est. Sep 2025
+1 more trials
Merit Medical
Merit MedicalSOUTH JORDAN, UT
1 program
Central Venous AccessN/A1 trial
Active Trials
NCT05050799Recruiting30Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Innovation PharmaceuticalsInsoles
Innovation PharmaceuticalsInsoles
Innovation PharmaceuticalsInsoles
Innovation PharmaceuticalsInsoles
Merit MedicalCentral Venous Access

Clinical Trials (5)

Total enrollment: 296 patients across 5 trials

Blinded Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return

Start: Aug 2025Est. completion: Sep 202554 patients
N/ACompleted

Investigate the Effect of EPITACT® Light Legs Therapeutic Insoles on the Symptoms and Quality of Life of Patients With Chronic Venous Disease

Start: Nov 2023Est. completion: Mar 202450 patients
N/ACompleted

Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group

Start: Oct 2023Est. completion: Feb 2024110 patients
N/ACompleted

Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return

Start: May 2023Est. completion: Jun 202352 patients
N/ACompleted
NCT05050799Merit MedicalCentral Venous Access

US Post-Market Surveillance Study of the Surfacer System

Start: Feb 2022Est. completion: Dec 202630 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 296 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.